Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01267682 · ClinicalTrials.gov registry record · Phase 2

Cognitive Intervention For Delirium in Dementia

A Phase 2 study, sponsored by Penn State University.

Completed
Registry status
Phase 2
Development phase
283
Enrollment target

NCT01267682: Completed Phase 2 study, sponsored by Penn State University.

NCT01267682 is a Phase 2 study that has completed, run by Penn State University. The registered enrollment target is 283 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (113% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01267682, a Phase 2 study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
Phase 2
Development phase
283 participants
Enrollment target

Study Summary

The purpose of this study is to test the effectiveness of cognitively stimulating activities for resolving delirium in people with dementia.

Interventions

  • BEHAVIORAL Cognitive Stimulation

Trial Details

FieldValue
Enrollment Target 283 participants
Start Date 2011-01
Est. Completion 2016-03
Phase Phase 2
Penn State University

219 total trials

What the finished NCT01267682 record still lists

NCT01267682 is an interventional study that assigns participants to a tested intervention. The registered 283 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (113% higher).

The record links to 0 conditions, and to 1 intervention - of which Cognitive Stimulation is the first listed.

NCT01267682 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01267682 about?

NCT01267682 is a clinical study titled "Cognitive Intervention For Delirium in Dementia". The purpose of this study is to test the effectiveness of cognitively stimulating activities for resolving delirium in people with dementia.

What is the current status of trial NCT01267682?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 283 participants. The study started on 2011-01. Estimated completion is 2016-03.

What interventions are being tested in trial NCT01267682?

The interventions under investigation include: Cognitive Stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01267682?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01267682's enrollment target sits among peer trials

283 195th of 2000 higher than 1,806 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06856694 · 283 participants · NA

    RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer

  • NCT05263206 · 284 participants · Phase 3

    Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

  • NCT05769218 · 284 participants · NA

    PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

  • NCT06856577 · 284 participants · Phase 3

    Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01267682, the US trial registry maintained by the National Library of Medicine. NCT01267682 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.